Quick Takeaways
- Squadron Capital Management LLC filed SCHEDULE 13G for PALISADE BIO, INC. Common Stock, par value $0.01 per share (PALI).
- Disclosed ownership: 8.5%.
- Date of event: 01 Oct 2025.
Quoteable Key Fact
"Squadron Capital Management LLC disclosed 8.5% ownership in PALISADE BIO, INC. Common Stock, par value $0.01 per share (PALI) on 01 Oct 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Squadron Master Fund LP | 7.6% | 7,308,580 | 0 | 7,308,580 | /s/ Matthew Sesterhenn | Partner, Squadron Partners LLC, its General Partner | |
| Squadron Capital Management LLC | 8.5% | 8,250,000 | 0 | 8,250,000 | /s/ Matthew Sesterhenn | Partner | |
| Matthew Sesterhenn | 8.5% | 8,250,000 | 0 | 8,250,000 | /s/ Matthew Sesterhenn | Matthew Sesterhenn | |
| William Blank | 8.5% | 8,250,000 | 0 | 8,250,000 | /s/ William Blank | William Blank |